| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research &Development | Director
3 companies
Malik Fady Ibraham is an EVP Research &Development at CYTOKINETICS INC with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 20 sells.
Estimated insider holdings value: $11.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 7,300 | $50.16 | $366,181.00 | -3.1% | -7.5% | +31.0% | |
| Nov 12, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 6,342 | $58.48 | $370,880.16 | -2.7% | -24.9% | +17.4% | |
| Oct 30, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 7,300 | $51.91 | $378,930.00 | -3.1% | -5.1% | +21.3% | |
| Oct 15, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 7,300 | $54.19 | $395,554.00 | -3.0% | -15.7% | +13.4% | |
| Oct 1, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 7,300 | $52.10 | $380,297.00 | -3.0% | -10.4% | +6.2% | |
| Sep 17, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 7,300 | $56.77 | $414,401.00 | -2.9% | -12.7% | -15.3% | |
| Sep 3, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 7,384 | $57.01 | $420,973.16 | -2.9% | -7.2% | -8.4% | |
| Aug 20, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 7,300 | $56.25 | $410,638.00 | -2.8% | -8.6% | -34.4% | |
| Aug 6, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 7,300 | $53.71 | $392,090.00 | -2.9% | -3.8% | -34.4% | |
| Jul 23, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 7,300 | $57.02 | $416,246.00 | -2.8% | -6.2% | -33.9% |